The experience of additional treatment of MDR-TB patients using autologous mesenchymal stem cells Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007
Potential role of autologous mesenchymal stromal cells in the treatment of multidrug and extensively drug-resistant tuberculosis Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant Source: Eur Respir J, 51 (5) 1702330; 10.1183/13993003.02330-2017 Year: 2018
Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis (M/XDR-TB): An open-label phase 1 safety trial Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014
Successful transplantation of rat mesenchymal stem cells, for the therapy of bleomycin induced lung injury Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis Year: 2010
Pulmonary function studies in hemato-oncologic children treated by chemoradiotherapy and stem cell transplantations Source: Annual Congress 2008 - Paediatric respiratory epidemiology I: primary ciliary dyskinesia, sleep-disordered breathing, exercise-induced symptoms and rare diseases Year: 2008
Pulmonary mycobacterial infection in allogeneic hematopoietic stem cell transplanted (HSCT) patients: A study of 7 cases Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011
The first experience of therapeutic dendritic cells vaccine administration in patients with extensively drug resistant lung tuberculosis Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018
The impact of bone marrow stem cells therapy in pulmonary and extrapulmonary acute lung injury Source: Annual Congress 2008 - Pathophysiology of acute lung injury Year: 2008
Pulmonary alveolar proteinosis and Mycobacterium abscessus lung infection related to ruxolitinib after allogeneic stem cell transplantation Source: Eur Respir J, 51 (5) 1701960; 10.1183/13993003.01960-2017 Year: 2018
Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015
Utility of bronchoscopy in hematopoietic stem cell transplant (HSCT) patients with pulmonary infiltrates: A prospective study. Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised Year: 2021
Stem cells, their niches, and evolving concepts concerning cancer Source: Annual Congress 2007 - Stem cells and the lung: the road from basics to clinics Year: 2007
Results immunophenotyping cultured autologous mesenchymal stromal cell of patients with COPD and IPF in Belarus Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015
Aerosolised delivery of mesenchymal stromal cells to the lungs: towards a novel therapy Source: International Congress 2017 – Repair of the emphysematous lung: mesenchymal stromal cell and matrix interactions Year: 2017
Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019
Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury Source: Eur Respir J 2009; 34: 740 Year: 2009
Oral presentation: Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009
A prospective, non randomized, clinical trial to study the safety and efficacy of the endobronchial autologous infusion of adipose-derived mesenchymal stem cells (ADMSCs) in patients with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - New insights in the treatment of idiopathic pulmonary fibrosis Year: 2011
Diagnostic value of bronchoalveolar lavage cell differentiation in patients with pulmonary complications after high dose chemotherapy and hematopoietic stem cell transplantation Source: Eur Respir J 2002; 20: Suppl. 38, 471s Year: 2002